GO:1903541 regulation of exosomal secretion: Secretory Pathway Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903541 (regulation of exosomal secretion) is a biological process term defined as any process that modulates the frequency, rate or extent of exosomal secretion.
• Exosome secretion is a multistep process involving endosomal sorting complexes required for transport (ESCRT) and ESCRT-independent pathways, and its regulation determines extracellular vesicle cargo release.
• Key regulatory genes include Rab GTPases, ESCRT components, and GPR143, which controls ESCRT-dependent exosome biogenesis and cancer metastasis.
• Dysregulated exosomal secretion contributes to cancer progression, neurological disorders, and metabolic diseases, making it a therapeutic target.
• CRISPR knockout, knock-in, and overexpression models are essential for dissecting the causal roles of specific genes in exosomal secretion.
• EDITGENE provides comprehensive CRISPR services, including library screening and bioinformatics, to accelerate research on regulation of exosomal secretion.
Description
Exosomes are small extracellular vesicles of endosomal origin that mediate intercellular communication by transferring proteins, lipids, and nucleic acids. The process by which exosomes are released from cells, termed exosomal secretion, is tightly regulated to control the composition and quantity of vesicles in the extracellular space. The Gene Ontology (GO) term GO:1903541, regulation of exosomal secretion, captures any process that modulates the frequency, rate, or extent of this secretion. Understanding this regulatory node is critical because exosomal secretion influences diverse physiological and pathological states, from immune responses to cancer metastasis. Research into GO:1903541 has revealed a complex interplay of molecular machinery, including the ESCRT pathway, Rab GTPases, and lipid-modifying enzymes. For instance, GPR143 has been shown to control ESCRT-dependent exosome biogenesis and promote cancer metastasis, highlighting the clinical relevance of this regulation. Moreover, exosomal secretion is affected by physiological states such as adipogenesis and antipsychotic treatment, underscoring its dynamic nature. Given its broad impact, GO:1903541 is a focal point for studies aiming to manipulate exosome production for therapeutic benefit. This article synthesizes current knowledge on the regulation of exosomal secretion, covering its definition, mechanisms, key genes, disease associations, and research methodologies, with a focus on CRISPR-based approaches for functional interrogation.
regulation of exosomal secretion At A Glance
| GO ID | GO:1903541 |
|---|---|
| GO term | regulation of exosomal secretion |
| Ontology | biological_process |
| Synonym | regulation of exosomal protein secretion; regulation of exosomal secretory pathway; regulation of extracellular vesicular exosome secretion; regulation of secretion of exosome |
| Major function | Modulates the frequency, rate or extent of exosomal secretion |
| Related processes | Exosome biogenesis, multivesicular body sorting, vesicle trafficking |
| Key regulators | ESCRT components, Rab GTPases, GPR143, lipids |
| Disease relevance | Cancer metastasis, neurological disorders, metabolic diseases |
What Is GO:1903541?
GO:1903541, regulation of exosomal secretion, is defined as any biological process that modulates the frequency, rate, or extent of exosomal secretion. This term encompasses the regulatory inputs that control the release of exosomes, which are extracellular vesicles formed in the endosomal compartment. It includes both positive and negative regulation, such as signaling events, protein-protein interactions, and transcriptional changes that ultimately influence the secretory pathway.
Why Is regulation of exosomal secretion Important in Cell Biology?
The regulation of exosomal secretion is fundamental to intercellular communication and is implicated in a wide range of physiological and pathological processes. Exosomes carry bioactive molecules that can reprogram recipient cells, and their secretion must be precisely controlled to maintain homeostasis. Dysregulation of this process contributes to cancer progression, neurodegenerative diseases, and immune dysfunction, making GO:1903541 a critical area for both basic and translational research.
• Exosomal secretion mediates intercellular transfer of proteins, RNAs, and lipids, influencing cell fate and behavior.
• Regulation of exosomal secretion is essential for normal physiological processes such as immune surveillance and tissue repair.
• Aberrant exosomal secretion is linked to cancer metastasis, with GPR143 promoting ESCRT-dependent exosome biogenesis.
• Exosomal miRNAs from adipose tissue are regulated during adipogenesis and affect metabolic states.
• Psychosis-altered miRNAs can be secreted via exosomes and are affected by antipsychotic drugs.
• Exosomal secretion in glioma modulates immune responses and therapeutic outcomes.
• Milk exosomes deliver miR-31-5p to accelerate diabetic wound healing, demonstrating therapeutic potential.
• Exosomal RNAs undergo glyco-modification, adding another layer of regulation.
• Targeting exosomal secretion pathways offers new strategies for drug delivery and disease intervention.
• CRISPR-based models enable precise dissection of regulatory genes in exosomal secretion.
What Happens During regulation of exosomal secretion?
Initiation of Exosome Biogenesis
In simple terms: The cell starts making exosomes inside a special compartment called the endosome.
Exosome biogenesis begins with the inward budding of the endosomal membrane to form intraluminal vesicles (ILVs) within multivesicular bodies (MVBs). This process is driven by the ESCRT machinery, which sorts cargo into ILVs, and by ESCRT-independent mechanisms involving lipids such as ceramide. Regulation at this stage determines the quantity and composition of exosomes that will eventually be secreted.
Cargo Sorting and MVB Maturation
In simple terms: Proteins and RNAs are packed into the exosomes, and the endosome gets ready to release them.
Cargo sorting into ILVs is a highly regulated step that selects specific proteins, RNAs, and lipids for exosomal release. ESCRT components such as TSG101 and CHMP4 recognize ubiquitinated cargo, while other factors like syntenin and ALIX facilitate specific sorting. The MVB then matures and can either fuse with lysosomes for degradation or with the plasma membrane for exosome secretion. Regulatory inputs at this stage, including Rab GTPases, influence the fate of MVBs.
Transport of MVBs to the Plasma Membrane
In simple terms: The endosome carrying exosomes moves to the cell surface.
MVBs are transported along cytoskeletal tracks to the plasma membrane, a process regulated by Rab GTPases such as Rab27a and Rab27b, and by motor proteins. This transport step is a key point of regulation, as it determines whether MVBs will fuse with the plasma membrane or be directed to lysosomes. GPR143 has been shown to control ESCRT-dependent exosome biogenesis and may influence this trafficking.
Fusion with Plasma Membrane and Exosome Release
In simple terms: The endosome fuses with the cell membrane, releasing exosomes outside the cell.
The final step of exosomal secretion is the fusion of MVBs with the plasma membrane, releasing ILVs as exosomes. This fusion is mediated by SNARE proteins, including VAMP7 and syntaxin-1, and is regulated by calcium signaling and Rab GTPases. The frequency and rate of this fusion event are the ultimate targets of regulation under GO:1903541.
Regulation by Extracellular Signals
In simple terms: Signals from outside the cell can speed up or slow down exosome release.
Extracellular cues such as growth factors, cytokines, and stress signals can modulate exosomal secretion. For example, antipsychotic drugs affect the secretion of a psychosis-altered miRNA via exosomes. Similarly, adipogenesis regulates exosomal secretion from adipose tissue. These signals often act through intracellular signaling cascades that converge on the core secretion machinery.
Key Genes Involved in GO:1903541 regulation of exosomal secretion
The following genes and proteins are key players in the regulation of exosomal secretion, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GPR143 | Controls ESCRT-dependent exosome biogenesis | Promotes cancer metastasis; potential therapeutic target |
| TSG101 | ESCRT-I component; cargo sorting into ILVs | Essential for exosome biogenesis; knockout reduces exosome secretion |
| CHMP4 | ESCRT-III component; membrane scission | Required for ILV formation; regulates exosome quantity |
| ALIX | ESCRT-associated protein; cargo sorting | Facilitates exosome biogenesis via syntenin |
| Rab27a | Regulates MVB docking and fusion | Knockdown decreases exosome secretion |
| Rab27b | Regulates MVB transport | Isoform-specific roles in exosome release |
| Rab35 | Regulates MVB fusion with plasma membrane | Modulates exosome secretion in various cell types |
| VAMP7 | SNARE protein; MVB-plasma membrane fusion | Required for exosome release |
| Syntaxin-1 | SNARE protein; fusion machinery | Regulates exosome secretion in neurons |
| Syntenin | Adaptor protein; binds ALIX and cargo | Promotes exosome biogenesis |
| Ceramide | Lipid; ESCRT-independent ILV formation | Regulates exosome secretion via sphingomyelinase |
| miR-31-5p | Exosomal miRNA cargo | Delivered via milk exosomes to promote angiogenesis |
| miR-137 | Psychosis-altered miRNA in exosomes | Regulates glutamate receptor expression; affected by antipsychotics |
| miR-21 | Exosomal miRNA in glioma | Modulates immune regulation and therapeutic responses |
| CD63 | Tetraspanin; exosome marker | Used for exosome characterization and isolation |
| CD81 | Tetraspanin; exosome marker | Enriched on exosomes; involved in cargo sorting |
| HSP70 | Chaperone; exosomal protein | Common exosome marker; involved in immune modulation |
How Is regulation of exosomal secretion Regulated?
The regulation of exosomal secretion is controlled at multiple levels, including transcriptional, post-transcriptional, and post-translational mechanisms. Signaling pathways such as mTOR and the integrated stress response (ISR) can influence exosome release by modulating protein synthesis and degradation. For instance, antipsychotic drugs alter the secretion of specific miRNAs via exosomes, indicating pharmacological regulation. Additionally, physiological states like adipogenesis regulate exosomal secretion from adipose tissue, highlighting metabolic control. The ESCRT pathway and Rab GTPases are subject to regulation by ubiquitination, phosphorylation, and lipid modifications. GPR143 represents a G-protein-coupled receptor that controls ESCRT-dependent exosome biogenesis, linking extracellular signals to intracellular machinery.
regulation of exosomal secretion and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GPR143 | Cancer metastasis | Knockout in melanoma cells; metastasis assay |
| miR-137 | Psychosis; glutamate receptor regulation | Overexpression in neuronal cells; antipsychotic treatment |
| miR-31-5p | Diabetic wound healing | Knock-in in milk exosomes; angiogenesis assay |
| miR-21 | Glioma immune regulation | Knockout in glioma cells; immune co-culture |
| Rab27a | Cancer progression; exosome secretion | Knockout in cancer cell lines; exosome quantification |
Cancer Metastasis
Exosomal secretion is hijacked by cancer cells to promote metastasis. GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis, suggesting that targeting this pathway could inhibit tumor spread. Exosomal miRNAs from glioma modulate immune responses and therapeutic resistance, further implicating exosomal secretion in cancer progression.
Neurological and Psychiatric Disorders
Exosomal secretion of a psychosis-altered miRNA that regulates glutamate receptor expression is affected by antipsychotics, linking exosomal regulation to psychiatric disorders. In the brain, exosomes mediate neuron-glia communication, and their dysregulation may contribute to neurodegeneration.
Metabolic and Inflammatory Diseases
Adipose tissue secretes exosomes that vary with physiological states, influencing metabolic homeostasis. Milk exosomes carrying miR-31-5p accelerate diabetic wound healing through promoting angiogenesis, demonstrating the therapeutic potential of exosomal secretion in metabolic and inflammatory conditions.
From regulation of exosomal secretion-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GPR143 regulate ESCRT-dependent exosome biogenesis? | GPR143 knockout cancer cells |
| What is the role of Rab27a in exosome secretion? | Rab27a knockout or knockdown cells |
| How does antipsychotic treatment affect exosomal miRNA secretion? | Neuronal cells with miR-137 overexpression |
| Can milk exosomes deliver functional miR-31-5p? | Knock-in of miR-31-5p in milk exosomes |
| Does TSG101 control exosome cargo sorting? | TSG101 knockout cells; proteomics |
| What is the effect of GPR143 point mutations on metastasis? | Point-mutation knock-in in cancer cells |
How to Study the regulation of exosomal secretion Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Nanoparticle tracking analysis | Size and concentration of exosomes | Quantifying secretion changes |
| Immunoblotting | Exosome marker proteins (CD63, CD81, TSG101) | Confirming exosome identity |
| Electron microscopy | Morphology of exosomes | Visualizing vesicles |
| Flow cytometry | Exosome-associated fluorescence | High-throughput secretion assays |
| RNA-seq | Exosomal RNA cargo | Identifying regulated miRNAs |
| Proteomics | Exosomal protein cargo | Discovering sorting mechanisms |
| CRISPR knockout | Gene function in exosomal secretion | Causal gene validation |
| CRISPR knock-in | Tagged protein localization and secretion | Tracking exosome cargo |
Exosome Isolation and Characterization
Differential ultracentrifugation, size-exclusion chromatography, and immunocapture are standard methods to isolate exosomes from conditioned media. Characterization involves electron microscopy, nanoparticle tracking analysis, and immunoblotting for markers like CD63, CD81, and TSG101.
Quantification of Exosomal Secretion
Fluorescent labeling of exosomes with lipophilic dyes or CD63-GFP allows quantification of secretion by flow cytometry or fluorescence microscopy. Alternatively, acetylcholinesterase activity or nanoparticle tracking analysis can measure exosome numbers.
Genetic Manipulation with CRISPR
CRISPR-Cas9 knockout, knock-in, and point mutation models are used to dissect the function of specific genes in exosomal secretion. For example, GPR143 knockout reduces exosome biogenesis and metastasis. Overexpression of tagged proteins enables tracking of exosome cargo.
Omics Approaches
RNA-seq and proteomics of exosomes and cells reveal changes in cargo and secretion machinery upon genetic or pharmacological perturbation. Glyco-modification of exosomal RNAs has been identified by mass spectrometry, adding a new dimension to exosome biology.
How CRISPR Can Be Used to Study GO:1903541 regulation of exosomal secretion
Knockout
CRISPR knockout of genes such as GPR143, TSG101, or Rab27a is used to determine their necessity in exosomal secretion. Knockout cells typically show reduced exosome release, which can be rescued by re-expression, confirming specificity.
Point Mutation
Point mutations can be introduced to dissect specific domains or residues required for exosomal secretion. For example, mutating GPR143 at key phosphorylation sites may reveal its regulation of ESCRT-dependent biogenesis. This approach is valuable for understanding post-translational control.
Knock-in
Knock-in of tagged proteins (e.g., CD63-GFP) allows real-time tracking of exosome secretion and cargo sorting. Knock-in of disease-associated mutations, such as those in GPR143, can model cancer metastasis.
Overexpression
Overexpression of regulatory genes or exosomal cargo (e.g., miR-31-5p) can enhance exosome secretion or alter cargo composition. This is useful for gain-of-function studies and therapeutic applications.
How EDITGENE Supports regulation of exosomal secretion Research
Researchers studying regulation of exosomal secretion-related genes often need to determine whether a candidate gene is causally involved in the secretory pathway or merely correlated with it. EDITGENE provides a suite of CRISPR-based services to enable precise genetic interrogation of exosomal secretion mechanisms.
Contact EDITGENE today to design your custom CRISPR model for regulation of exosomal secretion research.
Frequently Asked Questions About regulation of exosomal secretion
What is GO:1903541?
GO:1903541 is the Gene Ontology term for regulation of exosomal secretion, defined as any process that modulates the frequency, rate or extent of exosomal secretion.
What genes are involved in regulation of exosomal secretion?
Key genes include GPR143, TSG101, CHMP4, Rab27a, Rab27b, Rab35, VAMP7, and syntenin, among others.
How does GPR143 regulate exosomal secretion?
GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis.
What is the role of exosomes in cancer?
Exosomes mediate intercellular communication and can promote cancer metastasis by transferring oncogenic cargo.
How can I study regulation of exosomal secretion?
Methods include exosome isolation, nanoparticle tracking analysis, CRISPR knockout, and omics approaches.
What are the diseases associated with dysregulated exosomal secretion?
Cancer, neurological disorders, and metabolic diseases have been linked to altered exosomal secretion.
Can CRISPR be used to study exosomal secretion?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to dissect gene function in exosomal secretion.
What is the role of Rab27a in exosomal secretion?
Rab27a regulates MVB docking and fusion with the plasma membrane, and its knockdown decreases exosome secretion.
How do antipsychotics affect exosomal secretion?
Antipsychotics affect the secretion of a psychosis-altered miRNA via exosomes, which regulates glutamate receptor expression.
What services does EDITGENE offer for exosomal secretion research?
EDITGENE offers CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services.
Conclusion
The regulation of exosomal secretion (GO:1903541) is a dynamic and critical biological process that controls intercellular communication in health and disease. Key regulatory genes such as GPR143, Rab GTPases, and ESCRT components have been identified, and their dysfunction contributes to cancer, neurological, and metabolic disorders. Advances in CRISPR-based models and omics technologies are accelerating the dissection of this pathway, offering new opportunities for therapeutic intervention. EDITGENE stands ready to support researchers with tailored CRISPR solutions to unravel the complexities of exosomal secretion.
References
- 1. Arya SB et al.. 2024. The ins-and-outs of exosome biogenesis, secretion, and internalization.. Trends Cell Biol 34(2):90-108 PMID: 37507251
- 2. Abbas MA et al.. 2023. Regulation of adipogenesis by exosomal milk miRNA.. Rev Endocr Metab Disord 24(2):297-316 PMID: 36692804
- 3. Lee YJ et al.. 2023. GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis.. Dev Cell 58(4):320-334.e8 PMID: 36800996
- 4. Quan M et al.. 2020. Exosomal Secretion of Adipose Tissue during Various Physiological States.. Pharm Res 37(11):221 PMID: 33063193
- 5. Yan C et al.. 2022. Milk exosomes-mediated miR-31-5p delivery accelerates diabetic wound healing through promoting angiogenesis.. Drug Deliv 29(1):214-228 PMID: 34985397
- 6. Sharma S et al.. 2025. Extracellular exosomal RNAs are glyco-modified.. Nat Cell Biol 27(6):983-991 PMID: 40467769
- 7. Peng J et al.. 2021. Current Understanding of Exosomal MicroRNAs in Glioma Immune Regulation and Therapeutic Responses.. Front Immunol 12:813747 PMID: 35095909
- 8. Amoah SK et al.. 2020. Exosomal secretion of a psychosis-altered miRNA that regulates glutamate receptor expression is affected by antipsychotics.. Neuropsychopharmacology 45(4):656-665 PMID: 31775160
